Name | pentoxyverine |
Synonyms | Urex ucb2543 pentoxyverine Carbetapentane 1-phenyl-1-cyclopentanecarboxylate 2-(2-diethylaminoethoxy)ethyl1-phenylcyclopentanecarboxylate 2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate 2-(Diethylaminoethoxy)ethyl 1-phenyl-1-cyclopentanecarboxylate 1-phenylcyclopentane-1-carboxylicaciddiethylaminoethoxyethylester 1-Phenylcyclopentane-1-Carboxylic acid diethylaminoethoxyethyl ester 1-phenylcyclopentanecarboxylicacid2-(2-diethylaminoethoxy)ethylester 1-phenyl-cyclopentanecarboxylicaci2-(2-(diethylamino)ethoxy)ethylester 1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester |
CAS | 77-23-6 |
EINECS | 201-014-1 |
InChI | InChI=1/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3 |
Molecular Formula | C20H31NO3 |
Molar Mass | 333.46 |
Density | 1.048±0.06 g/cm3(Predicted) |
Boling Point | 165-170 °C (1.33Pa) |
Solubility | Dichloromethane (Slightly), Methanol (Slightly) |
Appearance | Oil |
Color | Clear Very Dark Red to Brown |
pKa | 9.69±0.25(Predicted) |
Storage Condition | Refrigerator |
Refractive Index | 1.4990-1.5010 |
Physical and Chemical Properties | Oily matter. The boiling point is 165-170 ° C. (1.33), and the refractive index is 5010-1. |
Use | Non-narcotic central antitussive drugs. The product with pentoxyverine citrate, also known as kebiqing. This is a class of non-addictive antitussive drugs, antitussive effect is inferior to codeine, more and to treat Upper Respiratory Infections caused by acute, mild Cough and pertussis, can reduce bronchial secretion. The toxicity of the product is low. |
Toxicity | LD50 oral in rat: 150mg/kg |
This product is 1-phenyl cyclopentane dicarboxylic acid -2-(2-diethylaminoethoxy) ethyl ester citrate. Calculated as dry product, containing no less than 98.5% of C20H31N03 • C6H807.
take this product, put the melting point in the capillary, decompression melting seal, according to the law (General 0612), the melting point is 88~93°C.
take 0.5g of this product, add 5ml of water, shake to dissolve, compared with No. 3 turbidity standard solution (General Principles 0902 first method), not more concentrated.
take 50mg of this product, put it in a 50ml measuring flask, add the mobile phase to dissolve and dilute to the scale, shake well, and use it as a test solution. Take 1ml for precision measurement and put it in a 100ml measuring flask, dilute to the scale with the mobile phase, shake, and serve as a control solution. According to the test of high performance liquid chromatography (General rule 0512), silica gel was bonded with eighteen alkyl silane as filler; Water (10ml of triethylamine, diluted to 3.0 ml with water, and adjusted to pH with phosphoric acid)-Methanol (45:55) as mobile phase; Detection wavelength was 215nm. The number of theoretical plates shall not be less than 2000 calculated by pentoverine peak, and the separation degree between pentoverine peak and adjacent impurity peaks shall meet the requirements. 20 u1 of the test solution and the control solution were respectively injected into the human liquid chromatograph, and the chromatogram was recorded to 3 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.2 times (0.2%) of the area of the main peak of the control solution, the sum of each impurity peak area shall not be greater than the main peak area of the control solution (1.0%).
take this product, put the phosphorus pentoxide dryer, at 60 deg C under reduced pressure drying to constant weight, weight loss should not exceed 1.0% (General rule 0831).
take l.Og of this product and check it according to law (General rule 0841). The residue left shall not exceed 0.1%.
The residue left under the ignition residue item shall not contain more than 15 parts per million of heavy metals as inspected by law (General rule 0821, Law II).
take this product about 0.4g, precision weighing, add glacial acetic acid 10ml dissolved, add crystal violet indicator liquid 1 drop, with perchloric acid titration solution (0.1 mol/L) titration to a blue color of the solution, and the results of the titration were corrected by a blank test. Per 1 ml of perchloric acid titrant (0.1 mmol/U corresponds to 52.56mg of C20H31N03. C6H807.
antitussive drugs.
sealed and stored in a dry place.
This product contains pentoxyverine citrate (C20H31N03 • C6H807) should be 90.0% to 110.0% of the label.
This product is sugar-coated tablets, White after removing the coating.
Same as pentoxyverine citrate.
25mg
sealed and stored in a dry place.
This product contains pentoxyverine citrate (C20H31N03 • C6H807) should be 90.0% to 110.0% of the label.
This product is a white drop pill.
take 4 capsules of this product, add water 5ml, slightly warm, dissolve pentoxyverine citrate, let it cool, filter, filtrate according to the identification of pentoxyverine citrate (1), (2), (4) test, showed the same reaction.
In addition to the dissolution time should be within 60 minutes, the other should be consistent with the relevant provisions under the pill (General Principle 0108).
Take 10 capsules of this product, add chloroform 20ml to dissolve pentoxyverine citrate, add 10ml glacial acetic acid and crystal violet indicator solution 1 drop, with perchloric acid titration solution (0.1 mol/L) titration to a blue color of the solution, and the results of the titration were corrected by a blank test. Each 1 ml of perchloric acid titration solution (0.1 mol/L) corresponds to 52.56mg of c20 h31no3. C6H8O7.
Same as pentoxyverine citrate.
25mg
sealed and stored in a dry place.
NIST chemical information | information provided by: webbook.nist.gov (external link) |
original and reference preparation | synthesis, developed by the Joint Chemical Company of Belgium (ucb) in 1956, was approved for production in Japan in 1963. Pentoxyverine Citrate Tablets 15mg, TSURUHARA, Japan, 1972. 2. Japanese reference: dainipponsumitmo Pharma Co., Ltd.,GAI-LESSTab. 10mg. 3. Domestic: Diao Group was first listed in the specification of 25mg in 1981. Specifications: 25mg, a total of 202 approval. No approval for domestic import. |
biological activity | Carbetapentane (Pentoxyverine, CB) is a kind of anticonvulsants non-Selective sigma-1 (λ1) agonist. |
Target | Value |
purpose | non-narcotic central antitussive. The product with pentoxyverine citrate, also known as kebiqing. This is a class of non-addictive antitussive drugs, antitussive effect is inferior to codeine, more and to treat Upper Respiratory Infections caused by acute, mild Cough and pertussis, can reduce bronchial secretion. The toxicity of the product is low. |
production method | is derived from tetrahydrofuran by ring opening, bromination, cyclization, hydrolysis, chlorination, and esterification. 1. Ring-opening and bromination tetrahydrofuran is added dropwise to hydrobromic acid, sulfuric acid is added dropwise, the reaction is then cooled to room temperature, the lower liquid is separated and washed with soda ash solution until neutral. After dehydration by addition of anhydrous calcium chloride, 1, 4-dibromobutane was obtained by filtration. 2. Cyclization Benzyl Cyanide was added to the dry reaction pot and 1, 4-dibromobutane was slowly added. 1-phenyl -1-cyano cyclopentane was obtained. 3. Hydrolysis water was added to the reaction pot and sulfuric acid and 1-phenyl-1-cyanocyclopentane were added with stirring to give 1-phenylcyclopentane carboxylic acid. 4. Chlorination 1-phenylcyclopentane carboxylic acid was dissolved in anhydrous trichloroethylene and phosphorus trichloride was added with stirring. After the reaction, the mixture was left to cool and separate into layers, and the supernatant was distilled under reduced pressure to recover trichloroethylene to obtain 1-phenylcyclopentane formyl chloride. 5. Esterification 1-phenylcyclopentane formyl chloride is added to a dry reaction pot, diethylaminoethoxyethanol is added dropwise, and after completion of the esterification, an oily substance pentoverine is obtained by acid-base treatment and activated carbon. |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |